Plasma SHBG levels are not only associated with a variety of benign endocrine diseases [25,26,27] but also affect the incidence of several sex hormone-dependent malignancies [28], such as low levels of circulating SHBG may increase the risk of breast, endometrial, and prostate cancer [29,30]. The gene discussed is SHBG; the disease is prostate carcinoma.